AQR Capital Management - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$477,184
-12.6%
29,547
+527.7%
0.00%0.0%
Q3 2021$546,000
-86.1%
4,707
-73.4%
0.00%
-85.7%
Q2 2021$3,922,000
+23.2%
17,680
-27.4%
0.01%
+40.0%
Q1 2021$3,184,000
+71.6%
24,349
+127.0%
0.01%
+66.7%
Q4 2020$1,856,000
-61.8%
10,727
-86.9%
0.00%
-62.5%
Q2 2020$4,863,000
-2.1%
82,003
+11.2%
0.01%0.0%
Q1 2020$4,966,000
+54.8%
73,751
+93.8%
0.01%
+100.0%
Q4 2019$3,208,000
+6.9%
38,065
-5.2%
0.00%0.0%
Q3 2019$3,002,000
+48.8%
40,138
+25.8%
0.00%
+100.0%
Q2 2019$2,017,000
+8.6%
31,899
-17.3%
0.00%0.0%
Q1 2019$1,857,000
+29.5%
38,557
-10.0%
0.00%0.0%
Q4 2018$1,434,000
-86.1%
42,818
-78.2%
0.00%
-80.0%
Q3 2018$10,308,000
+43.7%
196,711
-14.1%
0.01%
+42.9%
Q2 2018$7,171,000
+86.4%
229,110
+29.8%
0.01%
+75.0%
Q1 2018$3,847,000
+14.9%
176,461
+6.4%
0.00%0.0%
Q4 2017$3,349,000
+561.9%
165,796
+550.1%
0.00%
+300.0%
Q3 2017$506,00025,5040.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders